Free shipping on all orders over $ 500

 About 1 result found for searched term "1312299-39-0" (0.127 seconds)

Cat.No.  Name Target
M24605 Concizumab Others
NN 7415; mAb 2021 Anti-TFPI Recombinant Antibody
Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that binds to the Kunitz-type protease inhibitor (KPI) 2 structural domain of TFPI, thereby blocking the interaction of this structural domain with the FXa active site. Concizumab can be used in the study of haemophilia.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.